IL312709A - Inhibitors of 1,3,4,7-tetrahydro-2H-pyrrolo [3',2':5,6]pyrido[2,3-B] [1,4]oxazepine BC1-2 - Google Patents
Inhibitors of 1,3,4,7-tetrahydro-2H-pyrrolo [3',2':5,6]pyrido[2,3-B] [1,4]oxazepine BC1-2Info
- Publication number
- IL312709A IL312709A IL312709A IL31270924A IL312709A IL 312709 A IL312709 A IL 312709A IL 312709 A IL312709 A IL 312709A IL 31270924 A IL31270924 A IL 31270924A IL 312709 A IL312709 A IL 312709A
- Authority
- IL
- Israel
- Prior art keywords
- oxazepine
- pyrido
- pyrrolo
- tetrahydro
- inhibitors
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- YIOBXTCJTWWMJA-UHFFFAOYSA-N pyrido[2,3-b][1,4]oxazepine Chemical compound O1C=CC=NC2=CC=CN=C12 YIOBXTCJTWWMJA-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263267018P | 2022-01-21 | 2022-01-21 | |
| PCT/US2023/060944 WO2023141536A1 (en) | 2022-01-21 | 2023-01-20 | 1,3,4,7-tetrahydro-2h-pyrrolo [3',2':5,6] pyrido[2,3-b] [1,4] oxazepine bc1-2 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL312709A true IL312709A (en) | 2024-07-01 |
Family
ID=85382827
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL312709A IL312709A (en) | 2022-01-21 | 2023-01-20 | Inhibitors of 1,3,4,7-tetrahydro-2H-pyrrolo [3',2':5,6]pyrido[2,3-B] [1,4]oxazepine BC1-2 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US11964990B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4466273A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7714811B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240136972A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119053610A (cg-RX-API-DMAC7.html) |
| AR (1) | AR128310A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023210279A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3242074A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2024009334A2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL312709A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024008840A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202340210A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023141536A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202340210A (zh) * | 2022-01-21 | 2023-10-16 | 美商艾伯維有限公司 | 1,3,4,7-四氫-2H-吡咯并[3',2':5,6]吡啶并[2,3-b][1,4]氮呯Bcl-2抑制劑 |
| CN117820134A (zh) * | 2024-01-10 | 2024-04-05 | 山东盛安贝新材料有限公司南京分公司 | 一种顺式-3-甲氧基环丁胺盐酸盐的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020002032A (es) | 2017-08-23 | 2020-09-17 | Guangzhou Lupeng Pharmaceutical Company Ltd | Inhibidores de bcl-2. |
| US11903950B2 (en) | 2018-08-22 | 2024-02-20 | Newave Pharmaceutical Inc. | BCL-2 inhibitors |
| WO2020140005A2 (en) | 2018-12-29 | 2020-07-02 | Newave Pharmaceutical Inc. | Bcl-2 inhibitors |
| WO2021066873A1 (en) | 2019-10-03 | 2021-04-08 | Newave Pharmaceutical Inc. | Condensed heterocycles as bcl-2 inhibitors |
| WO2021083135A1 (en) | 2019-10-28 | 2021-05-06 | Beigene, Ltd. | Bcl-2 INHIBITORS |
| WO2021133817A1 (en) | 2019-12-27 | 2021-07-01 | Guangzhou Lupeng Pharmaceutical Company Ltd. | 1h-pyrrolo[2,3-b]pyridine derivatives as bcl-2 inhibitors for the treatment of neoplastic and autoimmune diseases |
| MX2022010410A (es) | 2020-02-24 | 2022-12-07 | Guangzhou Lupeng Pharmaceutical Company Ltd | Dispersiones de sólidos con extrusión por termofusión que contienen un inhibidor bcl2. |
| TW202340210A (zh) * | 2022-01-21 | 2023-10-16 | 美商艾伯維有限公司 | 1,3,4,7-四氫-2H-吡咯并[3',2':5,6]吡啶并[2,3-b][1,4]氮呯Bcl-2抑制劑 |
-
2023
- 2023-01-19 TW TW112102814A patent/TW202340210A/zh unknown
- 2023-01-19 US US18/156,987 patent/US11964990B2/en active Active
- 2023-01-20 KR KR1020247023725A patent/KR20240136972A/ko active Pending
- 2023-01-20 AR ARP230100132A patent/AR128310A1/es unknown
- 2023-01-20 WO PCT/US2023/060944 patent/WO2023141536A1/en not_active Ceased
- 2023-01-20 JP JP2024540933A patent/JP7714811B2/ja active Active
- 2023-01-20 CN CN202380016422.5A patent/CN119053610A/zh active Pending
- 2023-01-20 AU AU2023210279A patent/AU2023210279A1/en active Pending
- 2023-01-20 IL IL312709A patent/IL312709A/en unknown
- 2023-01-20 EP EP23707582.5A patent/EP4466273A1/en active Pending
- 2023-01-20 MX MX2024008840A patent/MX2024008840A/es unknown
- 2023-01-20 CA CA3242074A patent/CA3242074A1/en active Pending
-
2024
- 2024-03-05 US US18/595,898 patent/US20250066388A1/en not_active Abandoned
- 2024-07-15 CO CONC2024/0009334A patent/CO2024009334A2/es unknown
-
2025
- 2025-07-02 US US19/258,642 patent/US20260028356A1/en active Pending
- 2025-07-15 JP JP2025118767A patent/JP2025160251A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2023210279A1 (en) | 2024-05-23 |
| JP2025504382A (ja) | 2025-02-12 |
| CA3242074A1 (en) | 2023-07-27 |
| AR128310A1 (es) | 2024-04-17 |
| CO2024009334A2 (es) | 2024-07-18 |
| TW202340210A (zh) | 2023-10-16 |
| US20230234971A1 (en) | 2023-07-27 |
| KR20240136972A (ko) | 2024-09-19 |
| US20250066388A1 (en) | 2025-02-27 |
| MX2024008840A (es) | 2024-07-25 |
| EP4466273A1 (en) | 2024-11-27 |
| JP7714811B2 (ja) | 2025-07-29 |
| WO2023141536A1 (en) | 2023-07-27 |
| US11964990B2 (en) | 2024-04-23 |
| US20260028356A1 (en) | 2026-01-29 |
| CN119053610A (zh) | 2024-11-29 |
| JP2025160251A (ja) | 2025-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL284228A (en) | imidazo[1,2-b]pyridazine il-17a inhibitors | |
| IL289186A (en) | Compounds of 4,4a,5,7,8,8a - hexapyrido[4,3-b][1,4]oxazin-3-one as inhibitors of magl | |
| IL185510A0 (en) | Fused thieno [2,3-b] pyridine and thiazolo [5,4-b] pyridine compounds for inhibiting ksp kinesin activity | |
| NZ600161A (en) | Novel tricyclic compounds | |
| IL162461A0 (en) | Polymorphs of clopidogrel hydrogensulfate | |
| IL175813A0 (en) | PYRIDO [2,3-d] PYRIMIDINE-2,4-DIAMINES AS PDE 2 INHIBITORS | |
| ZA200504238B (en) | Thieno[3,2-b]pyridine-6-carbonitriles and thienoo[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors | |
| TW200738672A (en) | Intermediated for the preparation of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones | |
| IL151646A0 (en) | Use of pyrido[3,2-e]-pyrazinones as inhibitors of phosphodicesterase 5 for treating erectile dysfunction | |
| IL315842A (en) | Pyrido-[4,3-D]pyridazine amine derivatives are useful as NLRP3 derivatives | |
| ZA202210773B (en) | Pyrido[2,3-b] [1,4] oxazines or tetrahydropyrido[2,3-b][1,4] oxazepines as iap antagonists | |
| HK40120239A (en) | 1,3,4,7-tetrahydro-2h-pyrrolo [3',2':5,6] pyrido[2,3-b] [1,4] oxazepine bc1-2 inhibitors | |
| MX2024008840A (es) | Inhibidores de bcl-2 de 1,3,4,7-tetrahidro-2hpirrolo[3',2':5,6]pir ido[2,3-b][1,4]oxazepina. | |
| WO2007010138A3 (fr) | Derives de ν-(arylalkyl)-1h-pyrrolopyridine-2-carboxamides, leur preparation et leur application en therapeutique | |
| UA80881C2 (en) | New polymorphs of olanzapine hydrochloride | |
| SI1879893T1 (sl) | Postopek za izdelavo substituiranih H imidazo c kinolin aminskih spojin in intermediatov zanje | |
| PL4153599T3 (pl) | Sposób wytwarzania 7-amino-5-metylo-[1,2,5]oksadiazolo[3,4-b]pirydynokarboksylanu alkilu | |
| ZA200704709B (en) | A process for the preparation of substantially pure 4-mino-1-isobutyl-1H-imidazo[4,5-c]-quinoline (imiquimod) | |
| HK40088610A (en) | Pyrido[2,3-b] [1,4] oxazines or tetrahydropyrido[2,3-b][1,4] oxazepines as iap antagonists | |
| IL175957A0 (en) | Novel crystalline forms of 2,3 dimethyl-8-(2,6-dimethylbenzylamino)-n-hydroxyethyl-imidazo[1,2-a] pyridine-6-carboxamide mesylate salt | |
| ZA202406459B (en) | Pyrido[1,2-a]pyrimidin-4-one derivatives | |
| HK40130916A (en) | 3a,4,5,6-tetrahydro-1 h-pyrazolo[3,4-c]pyridin-7(7ah)-one derivatives as factor xiia inhibitors | |
| CA3271103A1 (en) | 3a,4,5,6-tetrahydro-1 h-pyrazolo[3,4-c]pyridin-7(7ah)-one derivatives as factor xiia inhibitors | |
| ZA200707302B (en) | Fused thieno [2,3-B] pyridine and thiazolo [5,4-B] pyridine compounds for inhibiting KSP kinesin activity | |
| PL363207A1 (en) | New derivative of pyrido [2,3-b] [1,4] diazepine and method for its production |